On July 20, 2026, Neogen Corporation (NASDAQ: NEOG), a leader in food safety and animal health testing, announced plans to release its financial results for the fourth quarter and full year of fiscal 2026 on July 30. Following the earnings report, the management team will host a conference call to discuss the results and address analyst questions.
- GF Valueā¢ verdict: $12.29 vs Current Price $10.22 = 16.8% undervalued
- GF Scoreā¢: 69/100, indicating a solid performance relative to peers
- Financial Strength: 4/10, suggesting moderate financial stability
What's Behind the News?
Neogen's upcoming earnings report is highly anticipated by investors and analysts alike. The company has been navigating a challenging market landscape, particularly in the food supply chain testing sector. Analysts project that Neogen's Q4 revenue will fall between $150 million and $155 million, with annual revenue expected around $590 million, reflecting a year-over-year growth of approximately 4%. Investors are keen to understand the recovery of demand in food supply chain testing, the market acceptance of new rapid testing products, and the anticipated synergies from the integration of 3M's food safety business, which Neogen acquired in 2022.
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. The company operates within the healthcare sector, specifically in the Medical Devices & Instruments industry, and has a market capitalization of approximately $2.23 billion. Neogen's comprehensive range of food safety testing products and animal genomics solutions positions it as a key player in ensuring food safety and animal health.
Is NEOG Overvalued or Undervalued?
According to GuruFocus, Neogen's GF Valueā¢ is calculated at $12.29, indicating that the stock is currently undervalued by approximately 16.8% with its current trading price at $10.22. This margin of safety suggests that investors may have an opportunity to purchase shares at a discount relative to their intrinsic value. The company's price-to-earnings (P/E) ratio is currently not available, but it is worth noting that the 5-year median P/E stands at 77.16, indicating that the stock has historically traded at a higher valuation.
For more insights, visit the GF Valueā¢ page.
What Does NEOG's GF Scoreā¢ Tell Us?
The GF Scoreā¢ ranks stocks from 0 to 100 based on five key aspects: Financial Strength, Profitability, Growth, Valuation, and Momentum. Stocks with higher GF Scoreā¢ values have been found to generate higher long-term returns (backtested 2006-2021).
| GF Scoreā¢ | 69 |
| Financial Strength | 4/10 |
| Profitability | 6/10 |
| Growth | 2/10 |
| Valuation | 10/10 |
| Momentum | 10/10 |
Neogen's strengths lie in its Valuation and Momentum ranks, both rated at 10/10, indicating that the stock is currently priced attractively and has shown positive price movements. However, the Growth rank of 2/10 suggests that the company may face challenges in expanding its revenue streams effectively. For further details, visit the NEOG stock page.
What Are Insiders Doing with NEOG Stock?
In the past three months, there has been no reported insider buying or selling activity for Neogen Corporation. This lack of insider transactions may indicate that insiders are currently holding their positions, reflecting their confidence in the company's future prospects.
What This Means for Investors
Overall, Neogen Corporation presents a compelling case for investors with its current undervaluation and solid GF Scoreā¢. The upcoming earnings report will be crucial in determining the company's trajectory, especially in light of recent challenges in the food supply chain testing market. Investors should keep an eye on the results and management's commentary during the conference call.
For the complete analysis, visit the NEOG stock page. You can also use the GuruFocus Stock Screener to find similar opportunities.
Frequently Asked Questions
What is NEOG's GF Scoreā¢?
NEOG's GF Scoreā¢ is currently 69/100, indicating a solid performance relative to its peers and suggesting potential for long-term returns.
Is NEOG overvalued or undervalued?
NEOG is currently undervalued, with a GF Valueā¢ of $12.29 compared to its current price of $10.22, representing a 16.8% discount.
What is NEOG's P/E ratio compared to historical?
NEOG's current P/E ratio is not available, but its 5-year median P/E is 77.16, suggesting that the stock has historically traded at a higher valuation.
This stock alert was generated using automated technology and GuruFocus financial data to provide readers with timely and accurate market reporting. This content was reviewed by GuruFocus editorial team prior to publication. Please send any questions or comments about this story to [email protected].
